510 related articles for article (PubMed ID: 26941184)
1. Nav1.7 and other voltage-gated sodium channels as drug targets for pain relief.
Emery EC; Luiz AP; Wood JN
Expert Opin Ther Targets; 2016 Aug; 20(8):975-83. PubMed ID: 26941184
[TBL] [Abstract][Full Text] [Related]
2. No gain, no pain: NaV1.7 as an analgesic target.
King GF; Vetter I
ACS Chem Neurosci; 2014 Sep; 5(9):749-51. PubMed ID: 25111714
[TBL] [Abstract][Full Text] [Related]
3. Endogenous opioids contribute to insensitivity to pain in humans and mice lacking sodium channel Nav1.7.
Minett MS; Pereira V; Sikandar S; Matsuyama A; Lolignier S; Kanellopoulos AH; Mancini F; Iannetti GD; Bogdanov YD; Santana-Varela S; Millet Q; Baskozos G; MacAllister R; Cox JJ; Zhao J; Wood JN
Nat Commun; 2015 Dec; 6():8967. PubMed ID: 26634308
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of ProTx-I and the novel venom peptide Pe1b provide insight into residues responsible for selective inhibition of the analgesic drug target Na
Rupasinghe DB; Herzig V; Vetter I; Dekan Z; Gilchrist J; Bosmans F; Alewood PF; Lewis RJ; King GF
Biochem Pharmacol; 2020 Nov; 181():114080. PubMed ID: 32511987
[TBL] [Abstract][Full Text] [Related]
5. Synergistic regulation of serotonin and opioid signaling contributes to pain insensitivity in Nav1.7 knockout mice.
Isensee J; Krahé L; Moeller K; Pereira V; Sexton JE; Sun X; Emery E; Wood JN; Hucho T
Sci Signal; 2017 Jan; 10(461):. PubMed ID: 28074005
[TBL] [Abstract][Full Text] [Related]
6. Na
McKerrall SJ; Sutherlin DP
Bioorg Med Chem Lett; 2018 Oct; 28(19):3141-3149. PubMed ID: 30139550
[TBL] [Abstract][Full Text] [Related]
7. Mining the Na
Chew LA; Bellampalli SS; Dustrude ET; Khanna R
Biochem Pharmacol; 2019 May; 163():9-20. PubMed ID: 30699328
[TBL] [Abstract][Full Text] [Related]
8. Pain behavior in SCN9A (Nav1.7) and SCN10A (Nav1.8) mutant rodent models.
Xue Y; Chidiac C; Herault Y; Gaveriaux-Ruff C
Neurosci Lett; 2021 May; 753():135844. PubMed ID: 33775738
[TBL] [Abstract][Full Text] [Related]
9. Insensitivity to Pain upon Adult-Onset Deletion of Nav1.7 or Its Blockade with Selective Inhibitors.
Shields SD; Deng L; Reese RM; Dourado M; Tao J; Foreman O; Chang JH; Hackos DH
J Neurosci; 2018 Nov; 38(47):10180-10201. PubMed ID: 30301756
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive engineering of the tarantula venom peptide huwentoxin-IV to inhibit the human voltage-gated sodium channel hNa
Neff RA; Flinspach M; Gibbs A; Shih AY; Minassian NA; Liu Y; Fellows R; Libiger O; Young S; Pennington MW; Hunter MJ; Wickenden AD
J Biol Chem; 2020 Jan; 295(5):1315-1327. PubMed ID: 31871053
[TBL] [Abstract][Full Text] [Related]
11. [Pain and analgesia : Mutations of voltage-gated sodium channels].
Eberhardt MJ; Leffler A
Schmerz; 2017 Feb; 31(1):14-22. PubMed ID: 27402262
[TBL] [Abstract][Full Text] [Related]
12. Future potential and status of selective sodium channel blockers for the treatment of pain.
Priest BT
Curr Opin Drug Discov Devel; 2009 Sep; 12(5):682-92. PubMed ID: 19736626
[TBL] [Abstract][Full Text] [Related]
13. Targeting voltage gated sodium channels NaV1.7, Na V1.8, and Na V1.9 for treatment of pathological cough.
Muroi Y; Undem BJ
Lung; 2014 Feb; 192(1):15-20. PubMed ID: 24272479
[TBL] [Abstract][Full Text] [Related]
14. A central mechanism of analgesia in mice and humans lacking the sodium channel Na
MacDonald DI; Sikandar S; Weiss J; Pyrski M; Luiz AP; Millet Q; Emery EC; Mancini F; Iannetti GD; Alles SRA; Arcangeletti M; Zhao J; Cox JJ; Brownstone RM; Zufall F; Wood JN
Neuron; 2021 May; 109(9):1497-1512.e6. PubMed ID: 33823138
[TBL] [Abstract][Full Text] [Related]
15. Nav1.7-A1632G Mutation from a Family with Inherited Erythromelalgia: Enhanced Firing of Dorsal Root Ganglia Neurons Evoked by Thermal Stimuli.
Yang Y; Huang J; Mis MA; Estacion M; Macala L; Shah P; Schulman BR; Horton DB; Dib-Hajj SD; Waxman SG
J Neurosci; 2016 Jul; 36(28):7511-22. PubMed ID: 27413160
[TBL] [Abstract][Full Text] [Related]
16. Discovery of aryl sulfonamide-selective Nav1.7 inhibitors with a highly hydrophobic ethanoanthracene core.
Wang JT; Zheng YM; Chen YT; Gu M; Gao ZB; Nan FJ
Acta Pharmacol Sin; 2020 Mar; 41(3):293-302. PubMed ID: 31316182
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Spider (
Gonçalves TC; Lesport P; Kuylle S; Stura E; Ciolek J; Mourier G; Servent D; Bourinet E; Benoit E; Gilles N
Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31443554
[TBL] [Abstract][Full Text] [Related]
18. Painful and painless mutations of SCN9A and SCN11A voltage-gated sodium channels.
Baker MD; Nassar MA
Pflugers Arch; 2020 Jul; 472(7):865-880. PubMed ID: 32601768
[TBL] [Abstract][Full Text] [Related]
19. Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
Mulcahy JV; Pajouhesh H; Beckley JT; Delwig A; Du Bois J; Hunter JC
J Med Chem; 2019 Oct; 62(19):8695-8710. PubMed ID: 31012583
[TBL] [Abstract][Full Text] [Related]
20. Newly Discovered Action of HpTx3 from Venom of Heteropoda
Wu X; Wang Z; Chen Y; Xu D; Zhang P; Wang X
Toxins (Basel); 2019 Nov; 11(12):. PubMed ID: 31757020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
